Patients with chronic health needs, including those with cancer, and their providers face numerous challenges during the COVID-19 pandemic. Survey results from 356 health care centers across 54 countries indicate that the impact of the COVID-19 pandemic on cancer care is widespread. Many centers reported challenges in delivering care, reduction in services, lack of personal protective equipment, staffing shortages, and limited access to medications. Respondents also reported potential patient harm due to interruptions in cancer-specific and non-cancer care.
Ralls MW, Blackwood A, Arnold MA, et al. Pediatrics. 2012;130:e1369-73.
National drug shortages have increased and emerged as a serious patient safety issue in the United States. Recently, a shortage of medicinal-grade ethanol occurred due to a temporary shutdown of the sole supplier. Ethanol lock therapy is used to reduce the incidence of catheter-related blood stream infections (CRBSI) in pediatric patients receiving parenteral nutrition due to intestinal failure. Although the details leading to the voluntary facility shutdown were not transparent, the authors suggest that it was likely due to the risk of an impending Food and Drug Administration inspection. During the shortage, the rate of CRBSI at one hospital rose dramatically, resulting in increased lengths of stay and hospital costs. This evidence illustrates profound financial and patient safety implications related to a national drug shortage.
Please select your preferred way to submit a case. Note that even if you have an account, you can still choose to submit a case as a guest. And if you do choose to submit as a logged-in user, your name will not be publicly associated with the case. Learn more information here.